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One  of the  basic  tenets  of the  clonal  selection  theory  is  that  antigen-specific 
precursor cells bear recognition structures directed toward a single antigenic specific- 
ity. Although the concept of clonal selection has been demonstrated at the level of B 
cell responses,  proof of clonally distributed  antigen  receptors on T  cells is  lacking. 
Recently, many laboratories have attempted to establish T  cell clones with specific 
immunologic  functions.  The  importance  of immortalized  T  cell  lines  with  such 
immunologic function in studying the T  cell receptor repertoire, mechanisms ofT cell 
activation,  and  cellular interactions between T  cells and  other immunocompetent 
cells is readily obvious. Initial attempts to derive immortalized T  cell clones centered 
around the production of immunologically competent T  cell hybridomas (1). There 
have  been  several  reports  of immunologically  functional  T  cell  hybridomas  that 
mediate  specific suppressor  function  (2-5).  More  recently, it  has  been  possible  to 
serially propagate cytotoxic T  lymphocytes in culture with conditioned media ob- 
tained from supernates of lectin-stimulated lymphocytes (6).  It has been possible to 
obtain  clones of cytotoxic T  cells  (7-9)  from these  long-term cultured  cytotoxic T 
lymphocytes. Another approach has been to develop alloreactive T  cell lines that are 
propagated  by  repeated  serial  restimulation  in  vitro  with  alloantigen  (10).  This 
technique has allowed the generation of long-term cultures of alloreactive T  cells from 
which alloreactive T  cell clones have been isolated in both the murine  (11-13) and 
human  (14,  15)  systems.  Recently Schreier et al.  (16)  have demonstrated  that  it is 
possible to propagate antigen-specific murine T cells in vitro in the presence of antigen 
and  major  histocompatibility  complex  (MHC)l-compatible  filler cells  resulting  in 
specific stepwise enrichment of antigen-induced proliferative cells. The data presented 
in this paper will outline the kinetics and specificity of  such long-term antigen-reactive 
T  cell lines and demonstrate our ability to isolate and characterize clones of antigen- 
reactive T  cells  that  recognize antigen  in  specific association  with  selected sets  of 
antigen-presenting cells. By studying clones of antigen-reactive T  cells obtained from 
long-term-cultured immune lymph node cells from an F1 mouse, it has been possible 
to  isolate  certain  clones  that  recognize antigen  only  in  association  with  antigen- 
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presenting determinants of cells of the F~ hybrid mouse, as well as clones that recognize 
antigen presented by cells of either of the parents and/or the  F]. Genetic mapping 
studies with recombinant congenic hybrid mice have suggested that the hybrid I-A- 
region-restricting element for T  cell clones reactive to  the synthetic random amino 
acid copolymer poly(L-Glun°,L-Ala3°,L-Tyrl°)n  (GAT) is the product of transcomple- 
mentation between LA  b and I-A  k regions. 
Materials and Methods 
Mice.  A/J, C57BL/6 (B6), A/J ×  B6)FI[(B6A)F1], and BALB/c mice were purchased from 
The Jackson Laboratory, Bar Harbor, Maine or bred from the stock in our animal facilities, 
Mayo  Clinic,  Rochester,  Minn.  B10.A(4R),  BI0.A(5R),  and  A.TL  mice  were  generously 
provided by Dr. Chella David, Mayo Medical School,  Rochester, Minn. B 10.MBR mice were 
generously provided by  Dr.  David Sachs,  Immunology Branch, National Cancer Institute, 
National Institutes of Health, Bethesda,  Md.  Hybrids between these recombinant congenic 
mice and The Jackson Laboratory stock listed above were bred in our animal breeding facilities 
at Mayo Clinic. Adult mice, aged 6-20 wk, were used in all experiments. 
Antigens and Mitogens.  GAT (lot  10)  was  purchased  from Miles Laboratories, Inc., Miles 
Research Products, Elkhart, Ind. Bovine serum albumin (BSA), phytohemagglutinin (PHA), 
and  concanavalin A  (Con  A)  were  obtained  from  Sigma  Chemical  Co.,  St.  Louis,  Mo. 
Lipopolysaccharide  (LPS)  was  obtained  from  Difco  Laboratories,  Detroit,  Mich.  Purified 
protein derivative of Bacillus tuberculosis (PPD) was purchased from Connaught Laboratories, 
Toronto,  Ontario,  Canada,  and  keyhole  limpet  hemocyanin  (KLH)  was  purchased  from 
Schwartz/Mann Div., Becton Dickinson & Co., Orangeburg, N. Y. 
Culture Medium.  Complete culture media consisted of RPMI-1640 (Grand Island Biological 
Co., Grand Island, N. Y.) that contained 10% fetal calf  serum (FCS) (Microbiological Associates, 
Walkersville, Md.), 3 ×  10  -5 M  2-mercaptoethanol, 12 mM Hepes,  100 U/ml penicillin, and 
100/Lg/ml streptomycin, e-glutamine was added at a final concentration of 2 ×  10 -3 M before 
use. For secondary in vitro restimulation of immune lymph node cells,  10% horse serum (HOS) 
was used instead of FCS. 
Immunization and Cell Cultures.  Mice (four to five/group) were immunized with 100 ~g GAT 
emulsified in complete Freund's adjuvant (Bacto-Adjuvant; Difco Laboratories) subcutaneously 
at  the base of the tail  (17).  7 d  later, draining lymph nodes (inguinal and paraaortic)  were 
removed, and single cell  suspensions were made and cultured in Costar trays (3524, Costar, 
Data Packaging, Cambridge, Mass.)  with 200 #g/ml GAT at a cell number of 6 ×  106 cells/ 
well in 1.5 ml RPMI-1640 HOS media. 4 d later, the cells were harvested, and blast cells were 
centrifuged on Ficoll-Paque at 2,000 rpm for 20 min. Cells from the interphase were collected, 
washed twice,  and recultured with 5 X  10  n irradiated (3,300 rad) syngeneic spleen cells (filler 
cells) at a concentration of 1 x  105 cells/ml in 2 ml RPMI-1640 FCS medium. After 14 d, the 
cells were  harvested and viable recovered cells were counted using the vital stain flourescein 
diacetate (FDA) (18). Briefly, FDA was added to an aliquot of cells to give a final concentration 
of 5 #g/ml. After 3-5 min at  room temperature, viable cells were brightly fluorescent when 
observed in a hemocytometer using a fluorescent microscope (Carl Zeiss, Inc., New York).  2 × 
105 viable recovered cells were restimulated with 200/zg/ml GAT in the presence of 50 X  105 
syngeneic irradiated  filler cells  in 2  ml  RPMI-1640 FCS  media.  After  4  d,  the cells  were 
harvested, and blast cells were recultured with syngeneic irradiated filler cells in the absence of 
antigen at a concentration of 1 ×  105 blast cells and 25 ×  105 filler cells/ml in 2 ml RPMI-1640 
FCS media for  an additional  14 d. GAT-reactive T  cells  have been maintained by this 4-d 
antigen restimulation followed  by  14-d resting culture and have been cultured over a  long 
period of time (> 8 mo at the current time). In some experiments where large numbers of cells 
were required, cells were restimulated and recultured in an upright position in culture flasks 
(3024; Falcon Labware Div., Becton Dickinson & Co., Oxnard, Calif.) in a total vol of 15 ml at 
the same concentrations of GAT, GAT-reactive T  cells, and filler cells. 
Assay of Proliferative Response.  14 d  after reculture, aliquots of viable recovered cells  were 
assayed  for  their  proliferative  response.  Variable  numbers of GAT-reactive T  cells  were 
restimulated with GAT in the presence of filler cells in 0.2 ml RPMI-1640 FCS media/well in MASAO KIMOTO AND C.  GARRISON  FATHMAN  761 
microtiter plates (3040; Falcon Labware Div., Becton Dickinson & Co.)  for 48 or 72 h. 2 #Ci of 
[3H]thymidine ([3H]TdR) (Research Products International  Corp., Elk Grove Village, Ill.) were 
added 16 h before harvest. Cells were harvested on a filter paper, and radioactivity was counted 
using standard scintillation counting (19).  Results were expressed  as the mean of triplicate 
cultures. The standard deviation of each mean was within 10%. 
Cloning of GAT-reactive T  Cells.  (B6A)Fa GAT-reactive T  cells were induced as described 
above. After the fourth 2-wk interval of reculture, the cells were restimulated with 200 p,g/ml 
GAT in the presence of syngeneic irradiated filler cells. 24 h later, the entire mixture of GAT- 
reactive T  cells, filler cells, and GAT was mixed with 0.5% agar (1:2 vol/vol) and placed on a 
supporting layer of 0.5% agar as described previously (11). The concentration of cells  in soft 
agar varied from 0.25  ×  l0  b to 5 ×  105 GAT-reactive T  cells each in the presence of 50 ×  106 
filler cells.  5-7  d  later, colonies were observed in the soft  agar and these were  picked and 
replated in individual microtiter wells with  1 ×  106 irradiated synegeneic filler cells  in the 
presence of 200 p,g/ml of GAT. For subcloning procedures, the same techniques were utilized, 
but with the addition of 10% Con A-activated rat spleen cell supernate at each of these two 
initial steps (13). Approximately 7 d after this antigen restimulation, the cells were transferred 
to Costar wells with fresh irradiated filler cells (10 ×  106/well) and fresh antigen, and subclones 
were removed from the influence of rat Con A supernate at this time. 7 d after this transfer, 
aliquots were removed from Costar wells and assayed as described above. Additionally, clones 
could be expanded in culture flasks as described above. 
Results 
Soluble-Antigen-Reactive  T  Cell Lines.  B6 mice were immunized with the synthetic 
random amino acid copolymer (GAT). The immune lymph node cells were obtained 
and stimulated as described in Materials and Methods. 2 wk after the second in vitro 
restimulation, viable recovered cells were tested for their reactivity against a  panel of 
selected  antigens and mitogens in the  presence of syngeneic irradiated spleen filler 
cells.  As shown  in Table I,  these  cells reacted  specificially with GAT and did  not 
recognize inappropriate antigens such as BSA or KLH. These cells did not react with 
PPD,  despite  the  fact  that  regional draining lymph  node cells obtained from  the 
immune mouse at time 0 reacted strongly with PPD (data not shown). Although these 
cells did not respond to the T  cell mitogen PHA nor to the B cell mitogen LPS, they 
demonstrated  strong  reactivity  to  the  T  cell  mitogen  Con  A  (Table  I).  Separate 
aliquots of these antigen-reactive  cells were stained for cell surface markers by indirect 
TABLE  1 
Antigen Specificity and Mitogen Responsiveness 
GAT*reactive  Antigen  :JH uptake 
T cells  or mitogen  #g/ml 
cpm 
B6  --  --  679 
B6  GAT  200  22,271 
B6  BSA  200  432 
B6  KLH  100  717 
B6  PPD  50  797 
B6  PHA  2.5  1,175 
B6  Con A  2  19,405 
B6  LPS  50  2,270 
B6 GAT-reactive cells were induced as described in Materials and Methods. After the third 2-wk interval 
of recuhure,  1 ×  104 viable recovered cells were assayed for reactivity on a selected panel of antigens or 
mitogens in the presence of 5 ×  l0  s syngeneic irradiated filler cells. Proliferative response was assayed on 
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immunofluorescence.  100% of these  cells  were  Thy-l.2  positive  and  there  were  no 
demonstrable surface-immunoglobulin-positive cells (data not shown). 
(B6A)F] GAT-reactive T cells were induced as described in Materials and Methods. 
Fig.  1 shows data obtained from an antigen dose-response study of such CAT-reactive 
T  cells, demonstrating their broad range of antigen reactivity: the optimal concentra- 
tion of GAT in the range studied was  100-200 #g/ml, although as little as  10/Lg/ml 
of GAT would stimulate these cells quite well. Although GAT-reactive T  calls showed 
vigorous proliferative responses in the presence of antigen and filler cells, they did not 
respond to GAT in the absence of filler cells (Table II). Furthermore, as reported by 
Schwartz et al.  (20) and Sehreier et al.  (16), there existed a necessity of MHC-region 
identity  between  responding  T  cells  and  the  irradiated  spleen  filler  cells  for  such 
GAT-induced  proliferative  responses.  The  data  presented  in  Table  III  in  which 
similarly propagated strain A GAT-reactive T  cells were restimulated in the presence 
10  5 
3 H u~lke 
(cDm)  104 
103 
4 x  102 
0  2  10  80  200 
OAT ~g/ml) 
Fla.  1.  Antigen dose-response ofGAT-reactive T  ceils. I ×  10  + (B6A)F] GAT-reactive T  cells were 
stimulated with various concentrations of GAT in  the presence of 5  ×  10  s syngeneic filler cells. 
Proliferative response was assayed on day 3. 
TABLE  II 
Requirements for Both Filler Cells and Antigen for T Cell Proliferation 
GAT-reactive T  cells  Filler cells  Antigen  OH uptake 
cpm 
(B6A) Fj  +  --  1,568 
(B6A) F~  +  GAT  53,199 
(B6A) F~  -  GAT  1,754 
l  X  104 (B6A)FI GAT-reactive T  cells were stimulated with 200/~g/ml of GAT in the presence or absence 
of 5 ×  105 syngeneic filler cells. Proliferative response was measured on day 2. 
TABLE  III 
MHC Requirements  for Anttgen Presentation 
GAT-reactive  Filler cells  MHC regions 
T  Cells  shared* 
aH uptake 
Medium  GAT 
cp?n 
A/J  A/J  All  727  13,363 
A/J  B6  None  1,834  3,650 
A/J  B 10.A(4R)  KA  1,470  10,962 
A/J  B 10.A(5R)  JECSD  2,320  4,329 
A/J  A.TL  ABJED  1,482  14,362 
1 X  104 A/J GAT-reactive T  cells were stimulated with 200/.tg/ml GAT in the presence of irradiated 
filler cells from various strains of mice. The proliferative response was measured on day 2. 
* The regions of the MHC that are shared between GAT-reactive T  cells and filler cells. MASAO KIMOTO AND C. GARRISON FATHMAN  763 
of a panel of antigen-presenting cells suggests that the ability of the antigen-presenting 
cells to effectively interact with the immune T  cells resides in the I-A region of the 
MHC [i.e., the ability of B 10.A(4R) and A.TL mice to present GAT effectively to the 
strain  A  GAT-reactive T  cells].  Likewise, B6 GAT-reactive T  cells could recognize 
antigen in association with B10.A(5R) antigen-presenting cells [but not B10.A(4R)], 
suggesting again the requirement for I-A- (or K) region sharing between the antigen- 
presenting cell and the T  proliferative cell (data not shown). 
Although such long-term-cultured GAT-reactive T  cells showed antigen specificity 
on  the  limited  panel  studied,  they still  retained  reactivity toward  alloantigens  as 
detected in  mixed lymphocyte cultures. The data presented in Table III suggested 
that the long-term-cultured GAT-reactive T cells demonstrated proliferative responses 
against  irradiated allogeneic spleen filler cells in the absence of antigen. We assayed 
their proliferative responses in the presence of irradiated spleen cells (in the absence 
of GAT) over 5 d  of mixed lymphocyte culture to characterize the alloreactivity of 
such long-term GAT-reactive T  cells. The kinetics of the proliferative response profile 
obtained from such GAT-reactive T  cells was typical of primary mixed lymphocyte 
reaction (MLR) responsiveness: the peak response being on day 5 or later (data not 
presented). 
Kinetics of Response of Soluble Antigen-Reactive T  Cells. The data in  Fig.  2  represent 
results obtained during an assay of several concentrations of GAT-reactive T  cells in 
the  presence of constant  amounts of GAT and  filler cells conducted on sequential 
days of culture. The magnitude of response is dependent upon the number of input 
antigen-primed  cells;  i.e.,  the  actual  counts per  minute doubled  as  the number of 
input antigen-primed cells doubled. This suggests that it is possible to quantitate such 
GAT-reactive T  cells. As can be seen from Fig. 2, the proliferative response peaked on 
day 4 with higher concentrations of GAT-reactive T  cells. When lower numbers of 
input  antigen-primed cells were used,  the apparent  logrithmic exponential growth 
pattern was maintained for longer periods of culture. This dose-response and kinetic 
pattern is very similar to that obtained from studying long-term-cultured alloreactive 
T  cells (19). 
Dose-Response of Filler Cells.  To clarify the role of filler cells in the GAT induced 
proliferative responses, a titratian experiment was performed in which the amounts of 
antigen and antigen-reactive T  cells were held constant and the irradiated syngeneic 
spleen filler cells were titrated downward (Fig. 3). The optimal number of syngeneic 
filler cells was  1 ×  106/well.  However, as few as  1.5  ×  104 filler cells/well provided 
significant  antigen  presentation  for  the  GAT-reactive  T  cells  in  the  presence  of 
antigen.  Hj0I !  !°0 
FIG. 2.  Kinetic  response of GAT-reactive  T ceils. Various numbers of (B6A)Fl GAT-reactive  T 
ceils were restimulated with 200/tg/ml GAT in the presence  of 5 ×  l0  s syngeneic filler cells. The 
proliferative  response  was assessed serially  for 5 d by [r3H]TdR  uptake after an overnight pulse with 
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F;c.  3.  Filler cell dose-response. 1 ×  104 (B6A)FI GAT-reactive T  cells were stimulated with 200 
#g/ml of GAT in the presence of various numbers of syngeneic filler cells. The proliferative response 
was assessed on day 3 by [3H]TdR uptake. 
Recognition of a Unique F~ Antigen-presenting Determinant.  Previous studies of in vitro 
secondary MLR have suggested that there exists a unique hybrid MLR-stimulating 
determinant(s) on (B6A)F1 mice (2i, 22). Additionally, studies of the recognition of 
Listeria monocytogenes-immune  T  cells in a murine system suggested the possibility that 
there were subpopulations of T  cells which uniquely saw L. monocytogenes as presented 
in  association  with  F1  cells  (23).  To look for such  a  unique  F1  antigen-presenting 
determinant,  we  induced  (B6A)F]  GAT-immune T  cells and  tested  their response 
against  antigen presented by either parental  A/J  or parental  B6, a  mixture of A/J 
and  B6 cells, or the  (B6A)FI splenic  filler cells.  The proliferative response of such 
(B6A)F]-immune  GAT-reactive  T  cells  to  antigen  in  association  with  syngeneic 
(B6A)F1  filler cells was higher in three separate experiments than that observed by 
antigen presentation either of parent A/J or B6, or an equal mixture of both (data 
not shown). These data suggest that there exist clones in the (B6A)F] immune cells 
that proliferate in response to antigen associated with a unique F1 determinant(s). To 
prove this hypothesis, we serially restimulated  these  (B6A)Fx GAT-reactive T  cells 
and cloned them in soft agar. 
GAT-reactive  T  Cell Clones.  (B6A)F1  immune GAT-reactive T  cells were cloned in 
soft agar as described in  Materials  and  Methods.  The initial  results of this cloning 
experiment  are  presented  in  Table  IV.  The  serially  restimulated  (B6A)Fa  GAT- 
reactive T  cells  responded  to  antigen  in  association  with  parental  A/J,  B6,  and 
(B6A)F1  filler cells. They also retained alloreactivity as evidenced by their response to 
allogeneic BALB/c filler cells. The colonies obtained from soft-agar cloning of this 
parental population can be classified into several types according to their reactivity 
patterns.  The  first  type  would  be  represented  by  colonies  that  recognized  GAT 
presented on either or both parental  filler cells A/J and B6, but not as well as they 
responded to GAT presented on syngeneic (B6A)Ft filler cells (data not shown). The 
most likely interpretation of the reactivities of colonies of this type was that they were 
not  truly cloned and  that  they contained contaminant  cells that  were in  the area 
surrounding  the  colony we  were  attempting  to  isolate  from soft  agar.  Subcloning 
experiments on  these  contaminated  colonies  are  reported  below  and  support  this 
interpretation. The second type would be represented by colonies 6-35 in Table IV 
that reacted to antigen equally well in the presence of either B6 or (B6A)F1 filler cells. 
The third type would be exemplified by colonies 3-43 that reacted to antigen only in 
the presence of (B6A)F1  filler cells.  These colonies did not respond to antigen in the 
presence of either parental filler cell or an equal mixture of cells from parent A/J and 
B6 (data not shown), suggesting that our hypothesis is correct: that there exist unique 
antigen-presenting  structures  on  F1  cells  that  allow  selected  clones  of Fl-immune 
GAT-reactive T  cells to respond to antigen. None of these colonies retained alloreac- MASAO KIMOTO AND C.  GARRISON FATltMAN 
TABLE IV 
Colonies of GA T-reactive T Cells 
765 
Antigen  --  GAT  GAT  GAT  -- 
Colony 
Filler cells  (B6A)F1  A/J  B6  (B6A)FI  BALB/c 
cpm 
Parental uncloned  704  1,835  7,111  16,282  4,107 
population 
6  941  719  8,498  11,727  253 
18  618  1,065  18,981  21,091  380 
28  356  737  15,583  12,049  523 
35  887  729  22,598  23,915  630 
3  661  510  520  3,398  169 
17  1,245  1,945  2,039  17,708  1,160 
36  554  500  655  5,079  308 
43  261  270  824  24,927  473 
(B6A)Fj GAT-reactive T cells were cloned in soft agar as described in Materials and Methods. 0.5 ×  104 
to 2 ×  104 GAT-reactive T cell clones were stimulated with 200/tg/ml  GAT in the presence of A/J, B6, or 
(B6A)Fj filler cells. Clones were also assayed for their  reactivity toward  allogeneic BALB/c irradiated 
spleen cells. The proliferative response was assayed on  day 3 by [:3H]TdR uptake.  The proliferative 
responses of the parental population from which these colonies were derived is included as control. 
tivity when  tested on BALB/c irradiated  spleen  cells.  Selected colonies were serially 
propagated  by restimulation  with  antigen  and  syngeneic  filler  cells.  These  colonies 
were assayed 4 or 6 wk later, and retained their specificity with time (data not shown). 
Subcloning with GA T-reactive T  Cell Colonies.  From our original soft agar cloning of 
F1-immune GAT-reactive T  cells, we obtained many colonies that exhibited  reactiv- 
ities  not  readily  identifiable  as  the  response  of single  clones.  These  colonies  had 
reactivity  for  antigen  presented  by  either  (or  both)  parental  filler  cells  but  much 
better reactivity for antigen presented by the syngeneic (B6A)F1 filler cells. The most 
likely interpretation of the reactivity of colonies of this type is that they were not truly 
cloned. In an attempt to prove this hypothesis, we subcloned one of these apparently 
contaminated  colonies  in  soft  agar  utilizing  procedures  outlined  in  Materials  and 
Methods.  The  colony  selected  for  subcloning,  colony  5,  exhibited  predominant 
reactivity  for  GAT  presented  in  association  with  (B6A)F1  cells,  although  it  had 
moderate reactivity for GAT in association with parental A/J antigen-presenting cells 
(Table  V).  Subclones  were  obtained  as  outlined  in  Materials  and  Methods.  The 
reactivity profile of several of these subclones obtained from soft agar is presented  in 
Table V. These data support our hypothesis that there exist unique antigen-presenting 
determinants  on F1 cells recognized by selected clones of Fa-immune GAT-reactive T 
cells. Additionally, the reactivity ofsubclone 12-5-a-24 suggests that our interpretation 
of contaminant  clones that  give rise  to the  apparently  mixed  reactivity ,patterns  of 
certain primary colonies is correct. 
Genetic Mapping  of Ft-specific  Antigen-presenting Determinants.  The  data  presented 
above  have  suggested  that  certain  T  cell  clones  derived  from  Fx-immune  mice 
recognize antigen  only in association  with  antigen-presenting  determinants  that  are 
unique to the F1 cells. TO genetically map the genes controlling the expression of such 
antigen-presenting  determinants  expressed  uniquely  on  (B6A)F1  antigen-presenting 
cells,  we assayed  the  response  of one of the GAT-reactive subclones  to GAT  in the 766  HYBRID  I-A PRODUCTS RESTRICT ANTIGEN RECOGNITION 
TABLE V 
Subclones of GA T-reactive Colony 12-5 
Subclone 
number 
A/J  B6  A/J + B6  (B6A)F, 
Medium GAT  Medium GAT  Medium GAT  Medium GAT 
cpm 
12-5"  238  2,080  144  350  570  2,722  253  22,521 
12-5-a-2  251  281  281  349  481  355  303  10,897 
12-5-a-27  235  248  26l  316  756  574  435  15,971 
12-5-a-31  426  348  351  338  755  1,207  519  15,654 
12-5-a-34  307  283  99  194  201  374  155  17,012 
12-5-a-24  396  16,221  270  1,174  959  17,747  162  10,590 
* Parental colony. 
One of the contaminant colonies obtained in the soft-agar cloning procedure described in Table IV was 
subcloned in soft agar in the presence of 10% rat Con A supernate as described in Materials and Methods. 
The reactivity of the parental colony 12-5 is included for comparison. 1 X 104 cells were restimulated 
with 200 #g/ml GAT in the presence of A/J, B6, equal mixtures of A/J + B6, and (B6A)FI filler cells. 
The total number of filler cells/well was 1 ×  108. The proliferative response was assayed on day 2 by 
[SH]TdR uptake. 
TABLE VI 
Transcomplementation in I-A of Hybrid Antigen-presentating Determinants 
MHC region 
Experi-  Filler cells  Medium  GAT 
ment  K  A  B  J  E  C  S  D 
A/J  k  k  k  k  k 
B6  b  b  b  b  b 
k  k  k  k  k 
n/J +  B6  g  g  g  g  g 
(B6A)FI  k/b  k/b  k/b  k/b  k/b  d/b 
BI0.A(4R)  k  k  b  b  b  b 
[Bt0.A(4R) XB6IF~  k/b  k/b  b/b  b/b  b/b  b/b 
d  d  d  178  340 
b  b  b  309  767 
d  d  d 
g  g  g  377  896 
d/b  d/b  36t  16,878 
b  b  436  955 
b/b  b/b  370  13,146 
(B6A)F,  k/b  k/b  k/b  k/b  k/b  d/b  d/b  d/b  1,547  35,350 
[B10.MBR × A.AL]Ft  b/k  k/k  k/k  k/k  k/k  k/k  k/k  q/d  788  1,055 
Subclone 12-5-a-2 (Table V) was assayed on filler cells from various strains and hybrid mice in a manner 
similar to that described for Table III. The MHC region of these mice have been included for clarity of 
presentation. Data are presented as the proliferative response assayed on day 2 by ['~H]TdR uptake. 
presence of filler cells derived from several congenic and recombinant F1 mice as listed 
in Table VI. As can be seen from these data, this subclone proliferated in response to 
GAT presented not only by syngeneic (B6A)F1 filler cells but also in response to GAT 
presented  by [B10.A(4R)  ×  B6]F1 antigen-presenting cells. A/J, B6, B10.A(4R), and 
(B10.MBR  ×  A.AL)Ft  spleen  cells  could  not  effectively  present  antigen  to  this 
subclone.  These  data  suggest  that  the  expression  of the  unique  hybrid  antigen- 
presenting determinant present on (B6A)F1 spleen cells is controlled by genes mapping 
within  the  I-A  subregions  of the  MHC.  Furthermore,  the  inability  of A/J,  B6, 
B10.A(4R),  and  (B10.MBR  ×  A.AL)F1 spleen  cells to present  antigen  suggests  that MASAO  KIMOTO AND  C.  GARRISON  FATHMAN  767 
the determinant  utilized for antigen presentation  to  this  particular clone of GAT 
immune T  cells is the product of transcomplementation between the I-A loci of strain 
A/J and strain B6. 
Discussion 
Despite many reports that have demonstrated the feasibility of maintaining long- 
term-cultured alloreactive T cells either by repeated stimulation with alloantigen (10) 
or by supplementation with exogenous growth factor (6),  it has until recently been 
difficult to culture conventional soluble antigen-specific T  cells for long periods of 
time. Ben-Sasson et al.  (24)  succeeded in maintaining antigen-specific guinea pig T 
lymphocytes in  culture  by  repeated  restimulation  with  antigen-pulsed  peritoneal 
macrophages for up to 5 wk. Recently, reports by Schreier et al. (16) and Watson (25) 
have demonstrated that it is possible to culture murine antigen-specific T  cells in the 
presence of syngeneic irradiated spleen filler ceils and conditioned media obtained 
from lectin-stimulated lymphocytes. Studies by Schreier et al. (M. Schreier. Personal 
communication.) have suggested that it is possible to isolate clones of murine T  cells 
reactive with determinants present on sheep erythrocytes. Studies by Sredni et al. (26) 
have suggested that it is possible to isolate antigen-specific T  cell clones directly from 
immune mice and propagate them in vitro by utilizing specific antigen, filler cells, 
and  supernates  from  lectin-stimulated  lymphocytes. The  results  described  in  this 
report  clearly demonstrate that  it  is  possible to culture soluble antigen-reactive T 
lymphocytes for long periods of time and to derive clones of antigen-reactive T  cells 
in the presence of antigen and irradiated syngeneic spleen filler cells without using 
any additional growth supporting factors such as culture supernates of lectin-stimu- 
lated lymphocytes. 
The  strict  requirement  for MHC  identity between  antigen-reactive T  cells and 
antigen-presenting cells has been well documented in antigen-driven T  cell prolifer- 
ative assays (27) and immune T  cell macrophage-binding studies (23). More detailed 
mapping  in  antigen-driven  murine  T  cell  proliferative  responses  has  shown  that 
identity is required only at the I-A subregion of the MHC between filler cells and 
antigen-reactive T  cells for proliferation in the presence of certain antigens (20).  As 
seen in Table III, strain A/J GAT-reactive T  cells respond to antigen in association 
with A/J B 10.A(4R), or A.TL filler cells, thus demonstrating the requirement for the 
1-A-subregion  identity between T  cells and antigen-presenting cells in this system. 
These data support the concept that T  cells do not recognize foreign antigen per se, 
but must recognize this antigen in association with cell surface Ia antigens (whether 
as altered self or dual recognition) to be activated. 
Dual clonality of F1 immune T  cells has been reported in antigen-induced T  cell 
proliferative responses (16, 28), helper T cell assay (29) and immune T cell macrophage 
binding assay (23).  In addition to T  cell subpopulations in such F1 immune popula- 
tions that recognize antigen in association with cells of one or the other of the parental 
types, the possibility has been suggested that there exists a third group of T cells that 
recognize antigen in association with an Fl-specific determinant (16, 23). The existence 
of an F1 hybrid determinant has been  demonstrated in the study of alloreactive T 
cells (21,  22),  and their clones (11-13).  Biochemical analysis of hybrid determinants 
(30),  as  well  as  serological  identification  of such  hybrid  determinants  has  been 
demonstrated (31). The data presented in this report clearly demonstrate that there 768  HYBRID 'I-A PRODUCTS RESTRICT ANTIGEN RECOGNITION 
exist  antigen-presenting determinants  expressed only on  (B6A)F1  cells  that  do  not 
exist  on  either parental  cell.  Furthermore,  these  data support  the existence T  cell 
clones in Fl-immune mice that recognize antigen in association with such Fa-specific 
antigen-presenting determinants. The expression of the Fx antigen-presenting deter- 
minant for (B6A)F1 anti-GAT responses was shown to be controlled by the I-A region 
of the murine MHC by analyzing the effectiveness of antigen presentation by cells 
derived from congenic recombinant hybrid mice (Tables III and VI). We suggest that 
the most likely possibility is that the (B6A)F1  antigen-presenting determinant recog- 
nized by the T cell clones described in this report is the hybrid I-A molecule consisting 
of either A,,kAB  b or A~bAI~  k molecules formed by transcomplementation between I-A 
loci in  the F1. These data support  the concept that  I-A a- and fl-chains can  freely 
associate in such F1 cells to create hybrid products that are expressed on the surface 
as Ia antigens that  function in antigen presentation. Such free combinatorial associ- 
ation of a- and fl-chains could result in expansion of the immunological capacity of 
F1  animals  if each  Ia antigen  created by such  association  functions as  an  antigen- 
presenting determinant and, as suggested by Benacerraf (32), exhibits antigen-recog- 
nition specificity unique to that molecular association. 
Summary 
Studies in our laboratory and elsewhere have shown that it is possible to propagate 
antigen-specific murine T  cells in vitro with resultant specific stepwise enrichment of 
antigen-induced  proliferative cells.  The  proliferative responses of these T  cells  are 
antigen specific and dependent upon the presence of antigen-presenting cells (spleen 
cells) that share the I-A subregion with the proliferating T  cell. Using techniques of 
soft-agar cloning, it has been further possible to isolate clones of antigen-reactive T 
lymphocytes from such long-term cultures. Data suggesting that these were clones of 
antigen-reactive  T  cells  were  obtained  by  studying  the  recognition  of antigen  in 
association  with  antigen-presenting  cells  with  a  panel  of such  clones  of antigen- 
reactive T  cells.  Proof of clonality was obtained by subcloning. 
Clones derived from Fl-immune mice can be divided into three separate categories: 
one clone recognizes antigen in association with antigen-presenting determinants of 
parent A and the F1; the second type recognizes antigen in association with antigen- 
presenting determinants of parent B and the F1; and the third type recognizes antigen 
only in  association  with  antigen-presenting determinants of the  Fa  mouse.  Genetic 
studies on the major histocompatibility complex requirements for antigen presentation 
to such Fl-reactive T  cell clones suggests that the hybrid antigen-presenting determi- 
nant in this system results from transcomplementation of products of the I-A region 
of haplotypes a and b. 
These studies  support  the  concept  developed  in  our  laboratory  that  there exist 
unique Fl  hybrid determinants on  (A/J  ×  C57BL/6)F1 cells and suggest  that these 
determinants can  be utilized  physiologically by hybrid mice in  immunocompetent 
cellular interactions. 
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